Prolonged colonisation withEscherichia coliO25:ST131 versus other extended-spectrum beta-lactamase-producingE. coliin a long-term care facility with high endemic level of rectal colonisation, the Netherlands, 2013 to 2014

Donor feces infusion for eradication of Extended Spectrum beta-Lactamase producing Escherichia coli in a patient with end stage renal disease

(2014) R. Singh et al.   CLINICAL MICROBIOLOGY AND INFECTION

Faecal carriage of extended-spectrum β-lactamase-producing Enterobacteriaceae is common 12 months after infection and is related to strain factors

(2014) E. Titelman et al.   CLINICAL MICROBIOLOGY AND INFECTION

Duration of colonization with antimicrobial-resistant bacteria after ICU discharge

(2014) Manon R. Haverkate et al.   INTENSIVE CARE MEDICINE

Measuring the quality of infection control in Dutch nursing homes using a standardized method; the Infection prevention RIsk Scan (IRIS)

(2014) Ina Willemsen et al.   Antimicrobial Resistance and Infection Control

Escherichia coli Sequence Type 131 Is a Dominant, Antimicrobial-Resistant Clonal Group Associated with Healthcare and Elderly Hosts

(2013) Ritu Banerjee et al.   INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY

Epidemiology of Multidrug-Resistant Microorganisms among Nursing Home Residents in Belgium

(2013) Béatrice Jans et al.   PLoS One

Transmission Dynamics of Extended-Spectrum β-lactamase–Producing Enterobacteriaceae in the Tertiary Care Hospital and the Household Setting

(2012) Markus Hilty et al.   CLINICAL INFECTIOUS DISEASES

Transmission dynamics of ESBL-producing Escherichia coli clones in rehabilitation wards at a tertiary care centre

(2012) A. Adler et al.   CLINICAL MICROBIOLOGY AND INFECTION

Colonization with Extended-Spectrum β-Lactamase-Producing Escherichia coli and Klebsiella Species in Long-Term Care Facility Residents

(2012) Ebbing Lautenbach et al.   INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY

Decontamination of cephalosporin-resistant Enterobacteriaceae during selective digestive tract decontamination in intensive care units

(2012) E. A. N. Oostdijk et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Evaluation of a DNA microarray for the rapid detection of extended-spectrum  -lactamases (TEM, SHV and CTX-M), plasmid-mediated cephalosporinases (CMY-2-like, DHA, FOX, ACC-1, ACT/MIR and CMY-1-like/MOX) and carbapenemases (KPC, OXA-48, VIM, IMP and NDM)

(2012) G. Cuzon et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Improved Multiplex PCR Strategy for Rapid Assignment of the Four Major Escherichia coli Phylogenetic Groups

(2012) M. Doumith et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Prevalence and Spread of Multidrug Resistant Escherichia coli Isolates Among Nursing Home Residents in the Southern Part of the Netherlands

(2012) C.F.M. van der Donk et al.   Journal of the American Medical Directors Association

Long-term carriage of extended-spectrum beta-lactamase-producing Escherichia coli

(2011) Rolf Alsterlund et al.   SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES

Costs of Bloodstream Infections Caused by Escherichia coli and Influence of Extended-Spectrum- -Lactamase Production and Inadequate Initial Antibiotic Therapy

(2010) M. Tumbarello et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Escherichia coliSequence Type ST131 as the Major Cause of Serious Multidrug‐ResistantE. coliInfections in the United States

(2010) James R. Johnson et al.   CLINICAL INFECTIOUS DISEASES

Real-time PCR for detection of the O25b-ST131 clone of Escherichia coli and its CTX-M-15-like extended-spectrum β-lactamases

(2010) Hiran Dhanji et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Rapid detection of TEM, SHV and CTX-M extended-spectrum β-lactamases in Enterobacteriaceae using ligation-mediated amplification with microarray analysis

(2010) J. Cohen Stuart et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Escherichia coli O25b-ST131: a pandemic, multiresistant, community-associated strain

(2010) B. A. Rogers et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Duration of colonisation by Enterobacteriaceae producing extended-spectrum β-lactamase and risk factors for persistent faecal carriage

(2010) J.R. Zahar et al.   JOURNAL OF HOSPITAL INFECTION

Effectiveness of a new decolonisation regimen for eradication of extended-spectrum β-lactamase-producing Enterobacteriaceae

(2010) M. Buehlmann et al.   JOURNAL OF HOSPITAL INFECTION

Multiresistant CTX-M-15 ESBL-producing Escherichia coli in southern Sweden: Description of an outbreak

(2009) Rolf Alsterlund et al.   SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES

Duration of Stool Colonization in Patients Infected with Extended‐Spectrum β‐Lactamase–ProducingEscherichia coliandKlebsiella pneumoniae

(2008) Anucha Apisarnthanarak et al.   CLINICAL INFECTIOUS DISEASES

Extended-spectrum β-lactamases in North America, 1987–2006

(2008) K. Bush   CLINICAL MICROBIOLOGY AND INFECTION

Prevalence and spread of extended-spectrum β-lactamase-producing Enterobacteriaceae in Europe

(2008) R. Cantón et al.   CLINICAL MICROBIOLOGY AND INFECTION

Faecal carriage of extended-spectrum  -lactamase-producing Escherichia coli: prevalence, risk factors and molecular epidemiology

(2008) J. Rodriguez-Bano et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

High Rate of Intestinal Colonization with Extended-Spectrum- -Lactamase-Producing Organisms in Household Contacts of Infected Community Patients

(2008) A. Valverde et al.   JOURNAL OF CLINICAL MICROBIOLOGY